Biological characteristics of esophageal squamous cell carcinoma associated with contiguous intraepithelial carcinoma

Diseases of the Esophagus

Volumn 10, Issue 2, 1997, Pages 128-133

  Ikeguchi, M ^a   Saitou, H ^a   Katano, K ^a   Tsujitani, S ^a   Maeta, M ^a   Kaibara, N ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CELL PROLIFERATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030958252     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1093/dote/10.2.128     Document Type: Article

References (14)

1. Soga J, Tanaka O, Sasaki K, Kawaguchi M, Muto T. Superficial spreading carcinoma of the esophagus. Cancer 1982; 50: 1641-1645.
2. Kuwano H, Matsuda H, Matsuoka H, Kai H, Okudaira Y, Sugimachi K. Intra-epithelial carcinoma concomitant with esophageal squamous cell carcinoma. Cancer 1987; 59: 783-787.
3. International Union against Cancer. TNM Classification of Malignant Tumors. 4th edn. New York: Springer-Verlag, 1987; 37-42.
4. Japanese Society for Esophageal Disease (7th edn.) Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976; 6: 69-78.
5. Hong M K, Laskin W B, Herman B E et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995; 75: 423-429.
6. Gerdes J, Lempke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by a monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
7. Yonemura Y, Ooyama S, Sugikawa K et al. Growth fractions in gastric carcinomas detected with monoclonal antibody Ki-67. Cancer 1990; 65: 1130-1134.
8. Gerdes J, Li L, Schlueter C et al. Immunobiochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-873.
9. Wintzer H-O, Zipfel I, Schulte-Mönting J, Hellerich U, von Kleist S. Ki-67 Immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991; 67: 421-428.
10. Kubota Y, Petras R E, Easley K A, Baure T W, Tubbs R R, Fazio V W. Ki-67-determined growth fraction versus Standard staining and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 1992; 70: 2602-2609.
11. Lam K-Y, Law S Y-K, So M K-P, Fok M, Ma L T, Wong J. Prognostic implication of proliferative markers M1B-1 and PC10 in esophageal squamous cell carcinoma. Cancer 1996; 77: 7-13.
12. Wakimoto H, Aoyagi M, Nakayama T et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996; 77: 373-380.
13. Maeta M, Koga S, Shimizu N, Inoue Y, Ishiguro M, Sawada T. Carcinogenic potential of the non-cancerous epithelium in patients with oesophageal cancer. Br J Surg 1988; 75: 531-532.
14. Kuwano H, Monta M, Matsuda H, Mon M, Sugimachi K. Histopathologic findings of minute foci of squamous cell carcinoma in the human esophagus. Cancer 1991; 68: 2617-2620.